Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5 studies found for:    SB-742457
Show Display Options
Rank Status Study
1 Completed A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease
Conditions: Mild-to-moderate Alzheimer's Disease;   Alzheimer's Disease
Interventions: Drug: SB-742457 15mg;   Drug: SB-742457 35mg;   Drug: Placebo;   Drug: donepezil 5-10mg
2 Completed A Study To Assess The Pharmacokinetics Of SB-742457 Formulated As A Capsule And A Tablet In Healthy Elderly Volunteers.
Condition: Alzheimer's Disease
Intervention: Drug: SB-742457
3 Completed Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: SB-742457;   Drug: Donepezil;   Drug: Placebo
4 Completed SB-742457 And Donepezil In Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: SB-742457;   Drug: donepezil
5 Completed A Dose Ranging Study To Investigate The Efficacy And Safety Of SB-742457 In Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: SB-742457

Indicates status has not been verified in more than two years